Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EXELIXIS, INC.EXEL · Entity 3386 | EVP, Commercial | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EXELIXIS, INC.
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 357,638 |
Reported balance
After 2026-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-20 · Sale · Disposed 32,110 · Balance 357,638 F1: Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $49.80 to $49.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2: Includes 356,992 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $49.80 to $49.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
F2: Includes 356,992 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2023 Filed May 18, 2023 00:09 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 8,765 | $19.18 | $168,112.70 |
DisclosureSEC source: 0000939767-23-000049 · wf-form4_168436855765148.xml · nonDerivative · entry 3 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,020 F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded March 4, 2022. Read SEC document |
| May 15, 2023 Filed May 18, 2023 00:09 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 6,274 | $19.18 | $120,335.32 |
DisclosureSEC source: 0000939767-23-000049 · wf-form4_168436855765148.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 324,785 F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded March 4, 2021. Read SEC document |
| May 15, 2023 Filed May 18, 2023 00:09 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 3,026 | $19.18 | $58,038.68 |
DisclosureSEC source: 0000939767-23-000049 · wf-form4_168436855765148.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,059 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded February 19, 2020. F2 · balance_after: Includes 185,767 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 1,508 shares of Exelixis, Inc. common stock acquired on April 28, 2023, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Read SEC document |
| April 03, 2023 Filed Apr 6, 2023 00:22 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 79,719 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-23-000036 · wf-form4_168074056722050.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,577 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on May 15, 2024 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested. F3 · balance_after: Includes 227,087 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 15, 2023 Filed Feb 18, 2023 02:44 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 1,556 | $18.08 | $28,132.48 |
DisclosureSEC source: 0000939767-23-000026 · wf-form4_167668825419022.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,858 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on December 15, 2021. F2 · balance_after: Includes 147,368 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 06, 2023 Filed Feb 9, 2023 01:17 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 25,000 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0000939767-23-000020 · wf-form4_167590540517971.xml · derivative · entry 5 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2023-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 11, 2020. Read SEC document |
| February 06, 2023 Filed Feb 9, 2023 01:17 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 25,000 | $17.37 | $434,250.00 |
DisclosureSEC source: 0000939767-23-000020 · wf-form4_167590540517971.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,414 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2022. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.30 to $17.50. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| February 06, 2023 Filed Feb 9, 2023 01:17 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 25,000 | $4.20 | $105,000.00 |
DisclosureSEC source: 0000939767-23-000020 · wf-form4_167590540517971.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 151,866 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 15, 2022 Filed Nov 18, 2022 01:48 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 7,177 | $16.71 | $119,927.67 |
DisclosureSEC source: 0000939767-22-000115 · wf-form4_166873605234275.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,414 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 11, 2020, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on September 30, 2021. F2 · balance_after: Includes 151,866 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| September 12, 2022 Filed Sep 14, 2022 23:57 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 40,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0000939767-22-000102 · wf-form4_166319981296750.xml · derivative · entry 5 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2022-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 60,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019. Read SEC document |
| September 12, 2022 Filed Sep 14, 2022 23:57 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 40,000 | $17.94 | $717,600.00 |
DisclosureSEC source: 0000939767-22-000102 · wf-form4_166319981296750.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,591 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2022. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.67 to $18.04. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| September 12, 2022 Filed Sep 14, 2022 23:57 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 40,000 | $6.21 | $248,400.00 |
DisclosureSEC source: 0000939767-22-000102 · wf-form4_166319981296750.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 166,341 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| August 03, 2022 Filed Aug 6, 2022 01:43 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 7,177 | $21.49 | $154,233.73 |
DisclosureSEC source: 0000939767-22-000085 · wf-form4_165975016490523.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,591 F5 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units earned on August 3, 2022. Read SEC document |
| August 03, 2022 Filed Aug 6, 2022 01:43 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 28,950 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000085 · wf-form4_165975016490523.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,768 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: On September 11, 2020, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 57,900 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the Target Shares vest upon the Committee's certification of achievement of certain performance criteria as certified by the Compensation Committee (the "Committee"); and (ii) 50% of the Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 200% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU. F3 · shares: On August 3, 2022, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 50% of the Target Shares subject to the PSU. Accordingly, the Committee's certification resulted in the immediate vesting of 25% of the Target Shares, and 25% of the Target Shares will vest on August 15, 2023, subject to the Reporting Person's continuous service through that date. The Reporting Person remains eligible for additional vesting depending the level and timing of achievement of the performance criteria through December 31, 2024. F4 · balance_after: Includes 166,341 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 00:28 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 18,812 | $18.21 | $342,566.52 |
DisclosureSEC source: 0000939767-22-000081 · wf-form4_165412971187892.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,818 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.19 to $18.31. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 151,866 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 15, 2022 Filed May 18, 2022 00:29 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 7,384 | $20.08 | $148,270.72 |
DisclosureSEC source: 0000939767-22-000063 · wf-form4_165283373524648.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,630 F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded March 4, 2021. Read SEC document |
| May 15, 2022 Filed May 18, 2022 00:29 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 4,339 | $20.08 | $87,127.12 |
DisclosureSEC source: 0000939767-22-000063 · wf-form4_165283373524648.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,014 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded February 19, 2020. F2 · balance_after: Includes 151,866 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 1,162 shares of Exelixis, Inc. common stock acquired on April 29, 2022, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0000939767-22-000041 · wf-form4_164911744920111.xml · derivative · entry 8 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 10,000 shares Expires 2022-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 60,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 10,000 | $23.00 | $230,000.00 |
DisclosureSEC source: 0000939767-22-000041 · wf-form4_164911744920111.xml · nonDerivative · entry 4 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,191 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 10,000 | $6.21 | $62,100.00 |
DisclosureSEC source: 0000939767-22-000041 · wf-form4_164911744920111.xml · nonDerivative · entry 3 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 00:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0000939767-22-000041 · wf-form4_164911744920111.xml · derivative · entry 7 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 10,000 shares Expires 2022-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 60,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 00:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 10,000 | $22.43 | $224,300.00 |
DisclosureSEC source: 0000939767-22-000041 · wf-form4_164911744920111.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,191 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2022. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.32 to $22.55. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 00:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 10,000 | $6.21 | $62,100.00 |
DisclosureSEC source: 0000939767-22-000041 · wf-form4_164911744920111.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 175,508 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 01:54 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 70,715 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000036 · wf-form4_164679082457042.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,191 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on May 15, 2023 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested. F3 · balance_after: Includes 175,508 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 01:09 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 31,238 | $19.53 | $610,078.14 |
DisclosureSEC source: 0000939767-22-000032 · wf-form4_164609696172106.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,476 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.53 to $19.57. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 104,793 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 15, 2022 Filed Feb 18, 2022 00:59 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 14,729 | $18.59 | $273,812.11 |
DisclosureSEC source: 0000939767-22-000017 · wf-form4_164514597737299.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,714 F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 20, 2019, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on February 3, 2021. Read SEC document |
| February 15, 2022 Filed Feb 18, 2022 00:59 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 798 | $18.59 | $14,834.82 |
DisclosureSEC source: 0000939767-22-000017 · wf-form4_164514597737299.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,443 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on February 3, 2021. F2 · balance_after: Includes 104,793 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 03, 2022 Filed Feb 5, 2022 02:52 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 60,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0000939767-22-000011 · wf-form4_164402950927512.xml · derivative · entry 5 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2022-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 85,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016. Read SEC document |
| February 03, 2022 Filed Feb 5, 2022 02:52 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 60,000 | $17.91 | $1,074,600.00 |
DisclosureSEC source: 0000939767-22-000011 · wf-form4_164402950927512.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,241 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2021. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.76 to $18.04. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| February 03, 2022 Filed Feb 5, 2022 02:52 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 60,000 | $1.90 | $114,000.00 |
DisclosureSEC source: 0000939767-22-000011 · wf-form4_164402950927512.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 136,748 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 01:38 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 1,556 | $17.00 | $26,452.00 |
DisclosureSEC source: 0000939767-21-000116 · wf-form4_163979150653476.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,241 F5 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on December 15, 2021. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 01:38 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 8,995 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000116 · wf-form4_163979150653476.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,797 F1 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit ("PSU") award under the Exelixis, Inc. 2017 Equity Incentive Plan covering 8,995 shares of common stock. The PSU award generally vests as follows: (i) 50% of the original number of shares subject to the award vest upon certification by the Compensation Committee (the "Committee") that Exelixis, Inc. has achieved certain performance criteria related to the submission of Investigational New Drug applications with the U.S. Food and Drug Administration, or equivalent applications or filings with a foreign governmental authority, with respect to product candidates discovered, in-licensed or acquired by Exelixis, Inc. (the "2018 PSU Goal"); and (ii) 50% of the original number of shares subject to the award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. F3 · shares: On December 15, 2021, the Committee convened to determine that the 2018 PSU Goal had been achieved, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% will vest on February 15, 2023, subject to the Reporting Person's continuous service through that date. F4 · balance_after: Includes 136,748 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 24, 2021 Filed Nov 27, 2021 00:39 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 17,236 | $17.25 | $297,321.00 |
DisclosureSEC source: 0000939767-21-000106 · wf-form4_163797353673102.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,802 F1 · balance_after: Includes 132,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 01:40 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 44,184 | $18.10 | $799,730.40 |
DisclosureSEC source: 0000939767-21-000104 · wf-form4_163719962398845.xml · nonDerivative · entry 3 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,038 F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 20, 2019, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on October 22, 2020. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 01:40 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 983 | $18.10 | $17,792.30 |
DisclosureSEC source: 0000939767-21-000104 · wf-form4_163719962398845.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,222 F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on September 2, 2020. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 01:40 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 4,323 | $18.10 | $78,246.30 |
DisclosureSEC source: 0000939767-21-000104 · wf-form4_163719962398845.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,205 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on October 3, 2017. F2 · balance_after: Includes 132,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| September 30, 2021 Filed Oct 5, 2021 00:08 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 5,416 | $20.63 | $111,732.08 |
DisclosureSEC source: 0000939767-21-000085 · wf-form4_163339247902642.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,528 F5 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on September 30, 2021. Read SEC document |
| September 30, 2021 Filed Oct 5, 2021 00:08 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 28,950 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000085 · wf-form4_163339247902642.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,944 F1 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: On September 11, 2020, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 57,900 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the Target Shares vest upon certification by the Compensation Committee (the "Committee") that Exelixis has achieved certain performance criteria; and (ii) 50% of the Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 200% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU. F3 · shares: On September 30, 2021, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 50% of the Target Shares subject to the PSU. Accordingly, the Committee's certification resulted in the immediate vesting of 25% of the Target Shares, and 25% of the Target Shares will vest on November 15, 2022, subject to the Reporting Person's continuous service through that date. The Reporting Person remains eligible for additional vesting depending the level and timing of achievement of the performance criteria through December 31, 2024. F4 · balance_after: Includes 236,115 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| September 16, 2021 Filed Sep 17, 2021 23:58 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000939767-21-000082 · wf-form4_163192306597853.xml · derivative · entry 5 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2021-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 120,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016. Read SEC document |
| September 16, 2021 Filed Sep 17, 2021 23:58 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 25,000 | $20.36 | $509,000.00 |
DisclosureSEC source: 0000939767-21-000082 · wf-form4_163192306597853.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,994 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2021. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.14 to $20.52. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| September 16, 2021 Filed Sep 17, 2021 23:58 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 25,000 | $1.70 | $42,500.00 |
DisclosureSEC source: 0000939767-21-000082 · wf-form4_163192306597853.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 221,640 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 18, 2021 Filed May 19, 2021 00:13 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 14,593 | $24.73 | $360,884.89 |
DisclosureSEC source: 0000939767-21-000055 · wf-form4_162138317439427.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,994 Read SEC document |
| May 15, 2021 Filed May 19, 2021 00:13 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 3,026 | $25.56 | $77,344.56 |
DisclosureSEC source: 0000939767-21-000055 · wf-form4_162138317439427.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,587 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded February 19, 2020. F2 · balance_after: Includes 221,640 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 1,221 shares of Exelixis, Inc. common stock acquired on April 30, 2021, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Read SEC document |
| April 26, 2021 Filed Apr 29, 2021 00:08 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 7,665 | $25.03 | $191,854.95 |
DisclosureSEC source: 0000939767-21-000042 · wf-form4_161965486730408.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,392 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2021. F2 · balance_after: Includes 230,390 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 04, 2021 Filed Mar 6, 2021 00:58 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 59,570 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000032 · wf-form4_161499230238974.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,057 F1 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on May 15, 2022 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested. F3 · balance_after: Includes 230,390 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 01:15 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 1,400 | $21.91 | $30,674.00 |
DisclosureSEC source: 0000939767-21-000020 · wf-form4_161361093670952.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,487 F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on December 4, 2019. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 01:15 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 45,000 | $21.57 | $970,650.00 |
DisclosureSEC source: 0000939767-21-000020 · wf-form4_161361093670952.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,887 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.54 to $21.62. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 170,820 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 02:15 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 11,267 | $22.56 | $254,183.52 |
DisclosureSEC source: 0000939767-21-000009 · wf-form4_161257769117964.xml · nonDerivative · entry 3 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,887 F8 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on February 3, 2021. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 02:15 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 59,411 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000009 · wf-form4_161257769117964.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,154 F1 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F5 · date: On September 20, 2019, the Reporting Person was granted a PSU award the under 2017 Equity Incentive Plan covering 118,821 (target amount for 2019 PSU) shares of common stock (such award, the "2019 Award," and such shares, the "Target Shares"). The 2019 Award generally vests as follows: (i) 50% of the Target Shares vest upon the Committee's certification of achievement certain performance criteria as certified by Committee; and (ii) 50% of the Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the 2019 Award provides for vesting of up to a maximum of 200% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the 2019 Award. F6 · shares: On February 3, 2021, the Committee determined the maximum performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 200% of the Target Shares subject to the 2019 Award. Accordingly, the Committee's certification resulted in the immediate vesting of 25% of the Target Shares, and the remaining 25% of the Target Shares will vest on February 15, 2022, subject to the Reporting Person's continuous service through that date. F7 · balance_after: Includes 174,868 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 02:15 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 4,498 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000009 · wf-form4_161257769117964.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,743 F1 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit ("PSU") award under the Exelixis, Inc. 2017 Equity Incentive Plan covering 4,498 shares (grant amount for 2018 PSU Goal #4) of common stock (such award, the "2018 Award"). The 2018 Award generally vests as follows: (i) 50% of the original number of shares subject to the 2018 Award vest upon certification by the Compensation Committee (the "Committee") that Exelixis has achieved certain performance criteria related to clinical trial enrollment or positive top-line results (the "2018 Goal"); and (ii) 50% of the original number of shares subject to the 2018 Award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. F3 · shares: On February 3, 2021, the Committee convened to determine that the 2018 Goal had been achieved, resulting in the immediate vesting of 50% of the 2018 Award, and the remaining 50% will vest on February 15, 2022, subject to the Reporting Person's continuous service through that date. F4 · balance_after: Includes 145,162 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.